Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × Rituximab × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 35 Lymphoma, Follicular 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma 20 Lymphoma, Mantle-Cell 19 Lymphoma, B-Cell, Marginal Zone 19 Lymphoma, Non-Hodgkin 18 Lymphoma, B-Cell 13 Recurrence 11 Burkitt Lymphoma 11 Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Waldenstrom Macroglobulinemia 7 Leukemia 5 Leukemia, Hairy Cell 4 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Heart Failure 2 Dendritic Cell Sarcoma, Interdigitating 2 beta-Thalassemia 1 Thalassemia 1 Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 trametinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 dabrafenib 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 etoposide phosphate 1 Vemurafenib 1 Sirolimus 1 LY3023414 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡